logo
Woman diagnosed with common UTI...now she's had to have all 4 limbs amputated because of little-known infection complication

Woman diagnosed with common UTI...now she's had to have all 4 limbs amputated because of little-known infection complication

Daily Mail​a day ago

A mother-of-two has urged people to learn the warning signs of sepsis after losing four of her limbs following a common infection.
Kim Smith, 63, from Milton Keynes, was left with blackened legs, feet and hands that needed to be amputated after a life-threatening ordeal left her in a coma for months.
In 2018, Mrs Smith was on holiday in Alicante, Spain with her husband Steve when she developed a urinary tract infection (UTI).
A UTI is a common infection where bacteria infiltrates parts of the body like the bladder, kidneys and urethra, causing a burning sensation when urinating.
Familiar with the common symptoms of a UTI—including needing to urinate more often and lower abdominal pain—Mrs Smith went to the doctors who prescribed her antibiotics.
But the pharmacist did not have her prescription available for collection that day, so the couple returned to their hotel, where Mrs Smith's condition quickly deteriorated.
'I woke up at 4am and I thought I was going to die,' she said in a TikTok video that has so far garnered over 793,000 views.
'I had severe breathlessness, slurred speech and confusion. I was really really cold. I had a fever and I was shivering like mad,' she added.
Her husband rushed her to the hospital where she was diagnosed with severe sepsis and put into a medically induced coma on November 29th.
Sepsis is a life-threatening reaction to an infection, which occurs when the body's immune system overreacts to an infection—like a UTI—and attacks its own tissue and organs.
By the next day, her hands had already turned purple.
'Spain had told my daughters that I had black digits, that's fingers and toes', Mrs Smith recalled.
'My arms were black up to [my elbows]'.
Eventually, after six weeks on life support, Mrs Smith was flown back to the UK, to Milton Keynes University Hospital, via air ambulance.
There, after three weeks back in the UK, Mrs Smith was gradually brought out from her coma.
'When I woke up, I could actually see that my hands and legs were black, so I knew that they would have to be amputated', she remembers.
Mrs Smith then underwent life-changing surgery to amputate her hands and legs above the knee.
Once she recovered from the quadruple amputation, the grandmother spent 12 weeks in physical rehabilitation, where she regained her strength and learnt to live without her limbs.
Now, Mrs Smith wants to raise awareness for the little-known risk associated with common UTIs.
'I want to tell you, if you need to go pee, go pee. Don't hold it—that could cause you to get an infection and that could develop into sepsis,' she said.
'The symptoms are severe breathlessness, slurred speech and confusion-I had that-I didn't pass much urine that day and I had a fever but I was really cold.'
'If you get anything like that, if you feel unusually unwell and you know something is not right, please please please advocate for yourself,' Mrs Smith urged her followers.
'Tell [doctors] something is not right and ask them to test you for sepsis.
'Ask for a second opinion if you have to. Do not leave if you feel something is wrong.'
UTIs affect the urinary tract, which includes the bladder, the urethra and the kidneys.
According to the NHS, common symptoms include pain or a burning sensation when peeing, needing to pass urine more often than usual, and cloudy looking urine––which can also be a sign of dehydration.
Some people may also experience lower abdominal or back pain, as well as a high temperature, chills or and a really low temperature below 36C.
These more severe symptoms could indicate a kidney infection, which can be serious if left untreated, developing into life-threatening sepsis.
Up to 1.7million people in the UK suffer from recurrent UTIs—classed as three or more infections a year.
Around half of all women will experience a UTI in their life time.
According to the World Health Organisation (WHO), sepsis kills 11 million people globally each year, while in the UK the infection claims around 48,000 lives.
People who suffer septic shock can develop small blood clots, which cut-off life-giving oxygen flow to the extremities.
The tissue then begins to die, and the skin turns black. However, if there is still enough healthy tissue, doctors may try to first remove the dead tissue—known as debriding.
If this treatment doesn't work, amputation is the next step.
UTIs are one of the most common causes of sepsis, dubbed the 'silent killer' because its symptoms can overlap with other conditions like the flu.
However, as Mrs Smith warns, knowing the symptoms of sepsis could save your life.
Tell-tale signs of sepsis in adults include appearing confused, slurred speech or not making sense, blue, grey or blotchy skin and difficulty breathing.
According to the NHS, a rash that doesn't fade when your roll a glass over it could be a tell-tale sign of the condition, as well as having a pale and blotchy appearance that is cold and clammy to the touch.
Sepsis affected skin may also develop pinprick bruises or large purple areas that can also turn blue, a sign the body is not getting enough oxygen.
Producing less urine than usual, for example not urinating for an entire day, is another potential sign of serious sepsis.
This is in part because a decrease in blood pressure caused by sepsis, as well as an increased risk of blood clots, can reduce blood supply to organs like the kidneys, which produce urine, impacting their function.
As the kidneys can be some of the first organs to start showing signs of reduced function due to sepsis, reduced urine production is considered a potential sign of the condition.
The NHS advises anyone who experiences these symptoms to call 999 or go to A&E immediately.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Beauty fans discover little-known product that works like 'MAGIC' on weak, brittle nails: 'I still can't believe the difference' (and it's 20% off right now)
Beauty fans discover little-known product that works like 'MAGIC' on weak, brittle nails: 'I still can't believe the difference' (and it's 20% off right now)

Daily Mail​

time29 minutes ago

  • Daily Mail​

Beauty fans discover little-known product that works like 'MAGIC' on weak, brittle nails: 'I still can't believe the difference' (and it's 20% off right now)

Beauty fans have discovered a little-known product that works like 'magic' on weak, brittle nails, and it's so popular that one sells every six minutes. The OPI Repair Mode Bond Building Serum is being hailed a 'game-changer' by reviewers who claim it dramatically transforms damaged nails in under a week - and it's currently on sale with 20 per cent off for MailOnline readers. OPI Repair Mode™ Bond Building Nail Serum OPI's Repair Mode™ Bond Building Nail Serum is a first-of-its-kind product with Patented Ulti-Plex Technology™ that penetrates the nail surface, for repair that starts from within. Hailed by beauty lovers as a 'wonder' product, the fast drying, easy to apply formula promises to deliver significantly stronger, shinier and healthier nails in just six days with regular use. £27.42 (save £2.48) Shop Resulting in a staggering 99 per cent keratin repair when used two times a day on bare nails for six days, this could be the solution to healthier nails Now, at a budget-friendly £27.42, it's cheaper than a trip to the salon and could leave you with '99 per cent nail keratin repair and stronger, smoother nails'. If your nails are being put through the wringer and are looking flakey and brittle, then scores of shoppers are recommending one nail serum time and time again. Going further than bog-standard nail strengtheners, the OPI Repair Mode Bond Building Nail Serum repairs nail keratin structure by penetrating the surface to build new bonds inside the natural nail. When used twice a day on bare nails for six days, there is a proven 99 per cent nail keratin repair, resulting in smoother, stronger nails. And now you can see the hype for yourself with our exclusive 20 per cent off code DMREPAIR20. Dubbed a 'confidence builder', the OPI nail serum is helping users grow their talons to new heights. 'It's magic,' one reviewer wrote. 'First time using, and I still can't believe the difference in my nails. I am so overwhelmed with this product.' Resulting in a staggering 99 per cent keratin repair when used two times a day on bare nails for six days, this could be 10 10-second daily solution to healthier nails. While a lot of repair products can take weeks to take effect, the OPI Repair Mode Bond Building Serum promises an improved appearance in nails after the first application. With continued use, users have seen smoother, stronger nails that are resistant to breakage and an improved appearance of ridges and colour. If your nails are weak and thin and struggling to grow, then applying the OPI Repair Mode Bond Building Nail Serum could be what you need to help your nails resist breaking. 'I have the weakest, flakiest nails possible,' another user explained. 'Had to stop using acrylics as I had a stubborn nail infection on two nails, so grew them out, started using this very expensive product and yes! 'Literally 6 weeks later I have a natural nail growth! I really didn't believe it was possible to achieve healthy nails after decades of abuse BUT I'm a convert.' Another OPI user agreed, also noticing an improvement in the texture of their nails: Repairs the nails and keeps up amazing structure and stops the nails from splitting, which I suffer from a lot!' Don't miss out on 20 per cent off with the discount code DMREPAIR20. But hurry, this code expires June 30 2025.

Blood cancer patients in England first in world to be offered ‘Trojan horse' drug
Blood cancer patients in England first in world to be offered ‘Trojan horse' drug

The Guardian

time3 hours ago

  • The Guardian

Blood cancer patients in England first in world to be offered ‘Trojan horse' drug

Thousands of patients in England with blood cancer will become the first in the world to be offered a pioneering 'Trojan horse' drug that sneaks inside cancer cells and wipes them out. In guidance published on Friday, the National Institute for Health and Care Excellence (Nice) gave the green light to belantamab mafodotin, which can halt the advance of multiple myeloma for three times as long as standard treatments. The targeted therapy, which is given as an infusion every three weeks with other cancer drugs, is a special type of antibody drug that targets and attaches to cancer cells. It has been described as a Trojan horse treatment because it works by being taken into a cancer cell and unleashing a high concentration of a lethal molecule to destroy the cell from inside. Prof Peter Johnson, NHS England's national clinical director for cancer, said the drug would be life-changing for patients and their families. 'Myeloma is an aggressive type of blood cancer, but we have seen a steady improvement in the outlook for patients over recent years as we have introduced new targeted therapies,' he said. 'I am delighted that patients in England will be the first to benefit from this new treatment, which has the potential to keep cancer at bay for years longer, giving people the chance of more precious time with friends and family.' About 1,500 patients a year in England with multiple myeloma, an incurable cancer of the bone marrow, will benefit from the treatment, also known as Blenrep and made by GlaxoSmithKline. Health officials said the drug would be offered to patients whose cancer had progressed or failed to respond to another first-line treatment. Shelagh McKinlay, the director of research and advocacy at the blood cancer charity Myeloma UK, said it was fantastic to see the NHS become the first healthcare system in the world to roll out the drug. 'We have been working very hard for the last year to get this treatment approved and we know it will transform the lives of thousands of people with myeloma,' she said. Paul Silvester, 60, from Sheffield, described the impact of the drug as amazing after he was diagnosed with myeloma in 2023. After the first treatment he received failed to stop his cancer progressing, he was given belantamab mafodotin through an early access programme at the Royal Hallamshire hospital. 'I feel like this treatment has brought the party balloons back in the house. It has been amazing – within the first two or three weeks, after the first dose, I was in remission,' he said. Trials suggest the treatment, in combination with bortezomib and dexamethasone, delays progression of the disease by an average of three years, compared with one year for patients taking the commonly used drug daratumumab along with the other treatments. Helen Knight, the director of medicines evaluation at Nice, said: 'This recommendation demonstrates our commitment to getting the best care to patients fast, while ensuring value for the taxpayer.' The health minister Karin Smyth said: 'This groundbreaking therapy puts the NHS at the forefront of cancer innovation. By harnessing cutting-edge 'Trojan horse' technology, we're offering new hope to blood cancer patients across the country.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store